Status:
COMPLETED
Hyperbaric Oxygen Therapy in Sickle Cell Pain
Lead Sponsor:
University of Nebraska
Conditions:
Vaso-occlusive Crisis
Sickle Cell Anemia Crisis
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Sickle cell anemia is a genetic blood disorder where red blood cells are abnormally shaped, crescent- or sickle-shaped, instead of the normal, round shape. This misshapen cell is rigid and sticky, cau...
Detailed Description
Sickle cell anemia is a genetic blood disorder where red blood cells are abnormally shaped, crescent- or sickle-shaped, instead of the normal, round shape. This misshapen cell is rigid and sticky, cau...
Eligibility Criteria
Inclusion
- 19 years old or older
- Present with an uncomplicated sickle cell crisis at admission friom the emergency department
Exclusion
- \< 19 years old
- pregnant female
- complicated sickle cell crisis present (i.e., concomitant MI, stroke, acute chest syndrome at time of presentation)
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2025
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03412045
Start Date
September 1 2022
End Date
June 5 2025
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity of Nebraska Medical Center
Omaha, Nebraska, United States, 68198